Position in VALN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$235,684
+$78,591 QoQ
Shares Held
45,064
+79.3% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#7
of 20 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VALN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IRONWOOD INVESTMENT MANAGEMENT LLC holds $13,113,875 across 6 Biotechnology names. VALN ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
56,589 | $4,820,816 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
61,163 | $4,555,420 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
113,387 | $1,924,177 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
52,080 | $1,339,497 | |
| 5 | REPL |
Replimune Group, Inc.
|
21,525 | $238,281 | |
| 6 | VALN |
Valneva SE
This page
|
45,064 | $235,684 |
All Filings in VALN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,684 | 45,064 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $157,093 | 25,135 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $221,690 | 25,135 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $306,647 | 25,135 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $142,515 | 25,135 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $167,897 | 25,022 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $109,396 | 25,022 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $151,132 | 25,022 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $175,404 | 25,022 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $198,174 | 25,022 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||